source
- Roche receives expanded FDA clearance for HER2 diagnostic tests linked to Jazz’s Ziihera cancer drugRoche announced that the U.S. Food and Drug Administration has broadened the clearance for two of its HER2 diagnostic assays, allowing their use in metastatic gastroesophageal adenocarcinoma. The…
- Chutes & Ladders—Vivace revs up C-suite ahead of pivotal pushVivace Therapeutics has named Craig Gibbs, Ph.D., as its new president and CEO.Fierce Biotech · 1d ago↗ source